enforc
cell
transdifferenti
human
cancer
cell
promis
altern
convent
chemotherapi
previous
identifi
albuminassoci
lipidand
specif
satur
fatti
acidinduc
transdifferenti
program
human
cancer
cell
hccl
studi
character
adipocytelik
cell
result
transdifferenti
human
cancer
cell
line
propos
common
mechanist
approach
transdifferenti
program
show
loss
pigment
cell
treat
albuminassoci
lipid
base
electron
microscop
analysi
overexpress
perilipin
western
blot
cell
treat
unsatur
fatti
acid
compar
gene
express
profil
naiv
melanoma
cell
albuminassoci
lipidtr
cell
base
rna
sequenc
confirm
transcript
upregul
key
adipogen
gene
marker
also
altern
splice
adipogen
master
regul
pparg
probabl
relat
report
regul
express
protein
importantli
result
also
show
upregul
gene
respons
clathrin
cltc
adaptorrel
protein
increas
cltc
express
transdifferenti
cell
confirm
western
blot
inactiv
cltc
chlorpromazin
chp
inhibitor
ctlc
mediat
endocytosi
cme
gene
silenc
sirna
partial
revers
accumul
neutral
lipid
observ
transdifferenti
cell
find
give
deeper
insight
phenotyp
chang
observ
hccl
adipocytelik
transdifferenti
point
toward
cme
key
pathway
distinct
transdifferenti
program
disclosur
simon
c
aguilargallardo
c
coinventor
intern
patent
applic
entitl
method
tumor
treatment
adipogenesi
differenti
transdifferenti
involv
reprogram
one
type
adult
cell
anoth
matur
cell
type
without
gener
intermediari
stem
cell
receiv
signific
attent
may
consider
number
applic
cell
cancer
therapi
success
transdifferenti
one
cell
type
anoth
overexpress
lineagespecif
gene
vivo
takeuchi
bruneau
zhou
et
al
vitro
graf
enver
ieda
et
al
previous
report
cell
transdifferenti
enforc
overexpress
appropri
set
gene
also
applic
specif
molecul
promis
altern
convent
chemotherapi
cancer
treatment
exampl
use
alltransretinoid
acid
atra
treatment
acut
promyelocit
leukemia
apl
kakizuka
et
al
fact
treatment
base
cell
differenti
therapi
solid
tumor
prompt
us
studi
whether
novel
transdifferenti
molecul
secret
human
embryon
stem
cell
hesc
could
prevent
cancer
progress
studi
show
irrespect
presenc
hesc
albuminassoci
lipid
albumax
w
specif
polyand
monounsatur
fatti
acid
linol
oleic
petroselin
palmitol
acid
account
transdifferenti
sever
distinct
human
cancer
cell
line
hccl
adipocytelik
cell
ruizvela
et
al
endocytosi
regul
entri
nutrient
hormon
signal
factor
cell
serv
regul
intern
transmembran
receptor
endocytosi
plasma
membran
invagin
form
new
intracellular
vesicl
contain
variou
cargo
molecul
materi
intern
extern
environ
conner
schmid
clathrin
cltc
mediat
endocytosi
cme
major
endocyt
rout
assum
regul
ligand
mediat
signal
transduct
disrupt
ligandreceptor
interact
uptak
endosom
compart
andersson
sequest
receptor
intracellular
compart
target
ligandreceptor
complex
lysosom
degrad
recycl
send
back
cell
surfac
reus
maxfield
mcgraw
sever
vitro
studi
report
evid
relationship
endocytosi
ligand
bone
morphogenet
protein
oxid
lowdens
lipoprotein
oxldl
bound
respect
receptor
key
role
differ
transdifferenti
model
rauch
et
al
yu
et
al
other
shown
incorpor
insulin
regul
glucos
transport
cell
plasma
membran
process
requir
adipogenesi
depend
clathrin
coat
vesicl
huang
et
al
howev
exist
direct
correl
endocyt
ligandreceptor
complex
intern
transcript
gene
control
critic
physiolog
event
cell
transdifferenti
adipogenesi
remain
larg
uninvestig
previou
report
identifi
similar
transdifferenti
program
hccl
complet
differ
origin
cell
ovarian
carcinoma
hepatocarcinoma
breast
adenocarcinoma
melanoma
ruizvela
et
al
studi
aim
character
adipocytelik
cell
result
melanoma
breast
carcinoma
transdifferenti
program
set
key
pathway
concomitantli
affect
program
order
document
inducedtransdifferenti
report
loss
pigment
cell
upregul
protein
express
studi
hccl
upregul
gene
express
commonli
consid
key
adipogen
marker
lipoprotein
lipas
lpl
peroxisom
proliferatoractiv
receptor
alpha
ppara
cell
result
also
reveal
altern
gene
splice
adipogen
master
regul
pparg
like
relat
upregul
protein
found
transdifferenti
cell
previous
report
group
ruizvela
et
al
importantli
result
also
show
increas
clathrin
cltc
express
provid
evid
clathrinmedi
endocytosi
cme
essenti
transdifferenti
program
breast
adenocarcinoma
melanoma
hccl
investig
adipocytelik
cell
cell
cultur
transfect
melanoma
attc
breast
adenocarcinoma
attc
cell
cultur
growth
media
contain
fetal
bovin
serum
fb
mm
glutamin
follow
standard
protocol
todaro
green
albuminassoci
lipid
obtain
ad
gibco
tm
albumax
ii
invitrogen
concentr
wv
rpmi
media
contain
fb
induc
cell
transdifferenti
cell
cultur
albuminassoci
lipid
wherea
mocktreat
cell
cultur
rpmi
contain
fb
hour
cell
trypsin
collect
plastic
tube
centrifug
rpm
cltctarget
sirna
scrambl
sirna
control
sirna
obtain
dharmacon
dharmacon
rna
technolog
sequenc
cltctarget
sirna
control
sirna
commerci
provid
cell
seed
accord
manufactur
protocol
serumcontain
media
without
antibiot
transfect
either
nm
sirna
nm
control
sirna
dharmafect
dharmacon
rna
technolog
antibioticfre
media
h
whole
genom
transcript
profil
control
cell
transdifferenti
cell
hour
incub
albuminassoci
lipid
obtain
rnaseq
briefli
total
rna
purifi
cell
cultur
use
quickrna
miniprep
tm
zymo
research
protocol
strandspecif
nt
pairend
solexa
librari
prepar
follow
dutp
method
parkhomchuk
et
al
levin
et
al
sequenc
read
map
human
genom
assembl
use
tophat
standard
paramet
indic
correspond
mate
inner
distanc
bp
h
bp
h
trapnel
et
al
gene
count
estim
use
htseqcount
http
wwwhuberembldeusersandershtseq
standard
paramet
use
human
annot
obtain
ensembl
differenti
express
gene
adipos
cell
type
estim
mean
noiseq
non
parametr
statist
method
tarazona
et
al
enrich
function
categori
calcul
goseq
method
young
et
al
adapt
fisher
exact
test
sequenc
data
assess
gene
differenti
express
three
technic
replic
per
sampl
analyz
total
sequenc
depth
milion
read
per
sampl
polyclon
antiactin
anticltc
antiadfp
anti
antibodi
purchas
abcam
w
cambridg
immunoblot
analysi
cell
extract
prepar
ripa
buffer
sigmaaldrich
w
contain
sd
protein
variou
lysat
separ
sd
page
bistri
gel
transfer
pvdf
membran
ge
healthcar
amersham
bioscienc
membran
incub
correspond
primari
antibodi
appropri
secondari
antibodi
protein
visual
standard
chemiluminesc
ge
healthcar
band
quantifi
densitometr
analysi
imag
quant
ecl
ge
healthcar
ratio
band
interest
correspond
actin
band
plot
electron
microscopi
malm
cell
transdifferenti
cell
hour
incub
albuminassoci
lipid
seed
permanox
slide
nalg
nunc
intern
napervil
il
densiti
cell
x
cm
well
cell
fix
glutaraldehyd
h
treat
osmium
tetroxid
h
rt
stain
uranyl
acet
away
light
h
cell
rins
sodium
phosphat
buffer
dehydr
ethanol
infiltr
overnight
araldit
resin
durcupan
fluka
buch
sg
switzerland
polymer
embed
cultur
detach
chamber
slide
glu
araldit
block
semithin
section
cut
ultracut
leica
heidelberg
germani
mount
onto
slide
stain
toluidin
blue
semithin
section
glu
araldit
block
detach
glass
slide
freezingthaw
cycl
use
liquid
nitrogen
ultrathin
section
prepar
ultracut
stain
lead
citrat
final
photomicrograph
obtain
fei
transmiss
electron
microscop
tecnai
spirit
use
digit
camera
soft
imag
system
olympu
neutral
lipid
quantif
perform
niler
greenspan
et
al
cell
wash
twice
pb
incub
nile
red
invitrogen
pb
min
incub
cell
filter
siev
celltric
partec
fluoresc
emiss
nm
regist
channel
beckman
coulter
flow
cytomet
fc
data
file
analyz
use
flowjo
flow
cytomet
analysi
softwar
lipid
droplet
ld
stain
oil
red
kutt
tsalta
stock
oil
red
solut
prepar
vortex
filter
siev
stain
cell
grown
plate
wash
twice
pb
fix
formaldehyd
panreac
min
fixat
cell
wash
time
pb
stain
oil
red
volum
stock
solut
volum
water
cell
wash
cold
pb
least
time
stain
filter
hematoxylin
sigmaaldrich
min
stain
cell
wash
pb
pictur
taken
phase
contrast
microscop
leica
dmil
use
leica
applic
suit
version
softwar
leica
microsystem
switzerland
first
check
chang
pigment
cell
chang
could
suggest
initi
transdifferenti
process
figur
show
pellet
cell
treat
albuminassoci
lipid
much
lighter
color
pellet
correspond
mocktreat
cell
indic
mark
loss
pigment
albuminassoci
lipidtr
cell
order
analyz
ultrastructur
featur
respons
observ
loss
pigment
treat
cell
use
electron
microscopi
em
em
studi
show
larg
cluster
dark
vesicl
mocktreat
cell
present
albuminassoci
lipidtr
cell
figur
addit
file
support
inform
c
higher
magnif
vesicl
hallmark
melanosom
respons
storag
melanin
pigment
raposo
mark
thu
em
studi
suggest
loss
pigment
due
impair
melanosom
biogenesi
melana
mlana
gene
express
restrict
melanocyt
melanoma
retin
pigment
epithelium
directli
implic
melanosom
biogenesi
de
mazier
et
al
rnaseq
data
indic
key
melanocyt
marker
downregul
foldchang
period
analyz
late
adipocyt
transdifferenti
marker
perilipin
lipoprotein
lipas
lpl
peroxisom
proliferatoractiv
receptor
alpha
ppara
increas
transdifferenti
cell
confirm
cell
effect
transdifferenti
adipocytelik
cell
check
presenc
hallmark
adipocyt
transdifferenti
lipid
storag
dropletassoci
protein
local
surfac
neutral
lipid
droplet
ld
adipocyt
brasaeml
et
al
heid
et
al
rnaseq
data
show
compar
control
cell
gene
express
upregul
fold
chang
albuminassoci
lipidtr
cell
hour
adipocyt
marker
gene
lipoprotein
lipas
lpl
peroxisom
proliferatoractiv
receptor
alpha
ppara
also
upregul
fold
chang
respect
western
blot
analysi
show
protein
absent
mocktreat
cell
cell
incub
vehicl
markedli
express
cell
incub
hour
albuminassoci
lipid
mixtur
linol
petroselin
acid
figur
cell
also
signific
increas
express
linol
petroselin
treat
cell
versu
vehicl
treat
cell
figur
deep
sequenc
analysi
transdifferenti
process
adipocytelik
cell
demonstr
implic
gene
particip
endocytosi
order
gain
insight
mechan
albuminassoci
lipid
enrich
media
act
transdifferenti
media
human
cancer
cell
line
hccl
ruizvela
et
al
ruizvela
et
al
examin
gene
express
cell
regul
transdifferenti
process
use
deep
sequenc
cultur
cell
rpmi
medium
presenc
albuminassoci
lipid
hour
neg
control
cell
cultur
contain
fetal
bovin
serum
rpmi
fb
period
time
mrna
extract
gene
express
quantifi
transcriptom
sequenc
rnaseq
gene
identifi
differenti
express
treat
untreat
cell
gene
express
analysi
adipocytelik
transdifferenti
demonstr
signific
upregul
gene
particip
function
relat
endocytosi
tabl
addit
file
support
inform
function
enrich
analysi
differenti
express
gene
also
indic
represent
gene
ontolog
go
term
relat
endocytosi
tabl
result
obtain
point
toward
upregul
cltc
adaptor
protein
involv
vesicl
coat
tabl
cltc
heavi
chain
cltchc
shown
upregul
fold
chang
adaptin
protein
adaptorrel
complex
fold
chang
fold
chang
fold
chang
fold
chang
synergin
fold
chang
fold
chang
also
upregul
import
compon
cltccoat
vesicl
mediat
intern
ligandreceptor
complex
transport
enzym
transgolgi
network
tgn
lysosom
pears
et
al
gene
express
analysi
reveal
upregul
cltc
sever
adaptin
protein
test
western
blot
analysi
cltc
protein
express
affect
cell
line
mocktreat
treat
albuminassoci
lipid
vehicl
petroselin
acid
hour
western
blot
analysi
figur
densitometr
analysi
obtain
band
reveal
cltc
protein
significantli
increas
cell
albuminassoci
lipidtr
group
compar
mocktreat
group
petroselin
acid
treat
group
compar
vehicl
treat
group
figur
ld
accumul
impair
low
temperatur
inhibitor
cme
endocyt
pathway
cltc
express
increas
cell
result
fatti
acid
coincub
decid
inhibit
cme
determin
whether
pathway
regul
transdifferenti
accumul
ld
known
hallmark
adipocyt
differenti
mersmann
et
al
quantifi
mean
fluoresc
dye
nile
red
greenspan
et
al
flow
cytometri
analysi
cme
process
inhibit
low
temperatur
sullivan
et
al
studi
effect
temperatur
ld
accumul
cell
kept
minut
presenc
petroselin
acid
nile
red
fluoresc
intens
drastic
reduc
cell
cell
compar
respect
control
figur
conclud
ld
accumul
figur
express
increas
cell
treat
albuminassoci
lipid
petroselin
linol
acid
cell
treat
albuminassoci
lipid
petroselin
acid
linol
acid
hour
western
blot
band
intens
correspond
normal
correspond
actin
band
sampl
b
averag
valu
densitometri
analys
three
separ
experi
shown
p
compar
control
studi
effect
cme
inhibit
transdifferenti
cell
pretreat
minut
chlorpromazin
chp
long
et
al
inou
et
al
drug
disrupt
cltcmediat
endocytosi
incub
petroselin
acid
presenc
inhibitor
minut
concentr
cell
nile
red
fluoresc
intens
drastic
reduc
cell
cell
compar
respect
control
figur
studi
suggest
ld
accumul
regul
cltcdepend
endocytosi
pathway
inhibit
pathway
attenu
transdifferenti
examin
depend
ld
biogenesi
cltcmediat
pathway
experi
cltctarget
sirna
conduct
figur
cltc
express
downregul
cell
cell
compar
control
sirnatransfect
cell
figur
transfect
figur
cltc
express
increas
cell
treat
albuminassoci
lipid
petroselin
acid
cell
treat
albuminassoci
lipid
petroselin
acid
hour
cell
lyse
separ
bistri
gel
probe
western
blot
antibodi
cltc
actin
western
blot
band
intens
correspond
cltc
normal
correspond
actin
band
sampl
b
averag
valu
densitometri
analys
three
separ
experi
shown
p
compar
control
hour
incub
period
petroselin
acid
flow
cytometri
analysi
ld
accumul
quantifi
mean
fluoresc
dye
nile
red
greenspan
et
al
show
cltc
deplet
markedli
diminish
accumul
ld
figur
c
fold
chang
induct
petroselin
acid
cltc
transient
silenc
significantli
reduc
fold
cell
cell
corrobor
inhibitori
effect
cltc
suppress
accumul
ld
employ
oil
red
dye
specif
bind
neutral
lipid
kutt
tsalta
transfect
hour
incub
period
petroselin
acid
cell
stain
oil
red
hematoxylin
figur
result
show
decreas
oil
red
stain
cltc
transient
silenc
figur
cell
corrobor
impair
neutral
lipid
accumul
cltc
suppress
altogeth
result
provid
strong
evid
cltc
silenc
caus
signific
chang
ld
accumul
adipocytelik
transdifferenti
cell
clinic
cancer
therapi
ie
chemotherapi
radiat
target
activ
prolifer
tumor
cell
figur
cltcdepend
endocytosi
pathway
regul
ld
accumul
nile
red
quantif
neutral
lipid
cell
greatli
reduc
low
temperatur
chp
b
cell
kept
min
presenc
petroselin
acid
cell
coincub
min
petroselin
acid
alon
chp
concentr
cell
cell
b
accumul
neutral
lipid
quantifi
nile
red
stain
experi
averag
valu
three
independ
analys
shown
p
compar
control
time
inevit
induc
therapyresist
cancer
cell
deriv
prolif
precursor
type
transdifferenti
agent
could
avoid
chemoand
radioresist
shift
balanc
prolifer
differenti
tumor
precursor
type
previou
studi
albuminassoci
lipid
found
induc
transdifferenti
hccl
toward
adipocytelik
cell
ruizvela
et
al
find
indic
connect
albuminassoci
lipid
pluripot
garciagonzalo
figur
see
legend
next
page
izpisua
belmont
far
complex
previous
anticip
addit
maintain
selfrenew
pluripot
hesc
garciagonzalo
izpisua
belmont
role
albumin
kalle
associ
lipid
davi
dubo
thoma
et
al
lafond
et
al
discov
adipogenesi
cell
type
schopfer
et
al
result
also
indic
certain
albumin
complex
associ
polyand
monounsatur
fatti
acid
induc
termin
differenti
arrest
cancer
progress
ruizvela
et
al
concomitanlti
studi
khan
et
al
also
describ
specif
growth
inhibit
ester
oleic
acid
ricinol
acid
human
skin
malign
melanoma
cell
line
khan
et
al
despit
import
find
describ
mani
key
question
remain
unansw
identif
novel
gene
protein
mediat
termin
transdifferenti
human
cancer
cell
get
better
understand
mechan
lead
transdifferenti
concentr
effort
role
gene
differenti
regul
process
em
reveal
mark
loss
pigment
melanoma
cell
treat
albuminassoci
lipid
accord
downregul
mlana
gene
express
melana
known
form
complex
affect
express
stabil
traffick
process
requir
melanosom
matur
express
indispens
function
format
cell
pigment
hoashi
et
al
quantif
gene
express
rnaseq
led
character
cell
treat
albuminassoci
lipid
sever
adipocyt
marker
lpl
ppara
significantli
upregul
ppara
could
upregul
mere
consequ
fatti
acid
accumul
shown
involv
regul
obes
rodent
increas
hepat
fatti
acid
oxid
kersten
et
al
lpl
well
describedadipocyt
marker
regul
hydrolysi
triglycerid
adipos
tissu
mead
et
al
interestingli
adipogenesi
marker
shown
upregul
upon
hccl
adipocyt
transdifferenti
ruizvela
et
al
show
differenti
map
pattern
albuminassoci
lipidtr
nontreat
cell
pparg
gene
eight
exon
translat
splice
differ
isoform
http
wwwensemblorghomosapiensgenesummari
isoform
primari
transcript
express
adipocyt
treat
cell
pparg
show
whole
transcript
express
mocktreat
cell
express
exon
evid
addit
file
support
inform
b
two
exon
encod
zinc
finger
bind
site
domain
transcript
factor
finn
et
al
lack
downregul
function
domain
nontreat
cell
might
indic
differenti
process
gene
cell
line
differenti
express
protein
ruizvela
et
al
character
adipocytelik
cell
show
express
increas
cell
treat
albuminassoci
lipid
petroselin
acid
princip
adipocyt
marker
coat
lipid
droplet
adipocyt
brasaeml
et
al
heid
et
al
express
link
previous
report
express
increas
cell
treat
albuminassoci
lipid
ruizvela
et
al
recent
report
pretreat
murin
preadipocyt
rosiglitazon
potent
agonist
decreas
lipolysi
increas
express
kim
et
al
quantif
gene
express
rnaseq
also
gave
us
clue
possibl
mechanist
pathway
involv
transdifferenti
among
gene
identifi
differenti
express
treat
untreat
condit
mani
relat
endocyt
function
albuminassoci
lipid
induc
transdifferenti
accompani
upregul
cltc
import
adaptorrel
complex
synergin
adaptorrel
protein
see
figur
previou
page
figur
inhibit
cltc
level
sirna
affect
ld
biogenesi
silenc
cltc
express
biogenesi
examin
nile
red
c
quantif
oil
red
semiquantit
determin
e
f
experi
perform
cell
c
e
cell
f
cell
transient
transfect
cont
control
sirna
cltc
sirna
hour
prior
addit
vehicl
hour
prior
cell
lysat
cell
lysat
separ
bistri
gel
probe
western
blot
antibodi
cltc
actin
experi
repeat
three
time
repres
western
blot
shown
cell
cell
b
neutral
lipid
determin
transfect
cell
treat
either
vehicl
petroselin
acid
hour
prior
test
nile
red
c
oil
red
hematoxylin
e
f
stain
perform
describ
materi
method
quantif
assess
use
flowjo
softwar
fold
induct
estim
calcul
ratio
treat
condit
petroselin
acid
untreat
condit
vehicl
averag
valu
three
independ
analys
shown
p
compar
control
c
repres
photo
shown
e
f
length
shown
size
bar
key
compon
clathrin
coat
vesicl
bind
directli
clathrin
lattic
lipid
protein
compon
membran
pears
et
al
found
coat
vesicl
locat
golgi
complex
suggest
associ
transport
vesicl
mediat
distinct
intracellular
sort
event
level
tgn
endosom
rat
adipocyt
gillingham
et
al
observ
upregul
protein
involv
traffick
could
relat
acquisit
adipocyt
phenotyp
encourag
western
blot
result
show
clear
overexpress
cltc
protein
transdifferenti
cell
decid
determin
role
cme
adipogen
transdifferenti
process
cell
transient
cltc
silenc
accomplish
sirna
caus
signific
reduct
ld
accumul
induc
petroselin
acid
microscop
analysi
oil
red
hematoxylin
stain
cell
suggest
ld
accumul
also
neutral
lipid
composit
ld
affect
cltc
silenc
far
studi
report
induct
cltc
express
cme
stimul
monounsatur
fatti
acid
although
polyunsatur
fatti
acid
found
play
role
format
synapt
vesicl
promot
vesicl
bud
membran
traffick
dario
davletov
chernomordik
et
al
chernomordik
et
al
recent
report
express
coupl
exposur
physiolog
level
polyunsatur
fatti
acid
enhanc
cltc
mediat
endocytosi
neuron
nonneuron
cultur
cell
ben
gedalya
et
al
transferrin
receptor
tfr
whose
gene
express
upregul
fold
chang
albuminassoci
lipidtr
cell
tabl
intern
cell
plasma
membran
recycl
back
cell
plasma
membran
specif
via
cme
hanov
et
al
eljack
et
al
report
murin
preadipocyt
differenti
media
previous
describ
stephen
et
al
show
gradual
increas
whole
cell
tfr
level
decreas
cell
surfac
tfr
level
eljack
et
al
result
obtain
studi
indic
differenti
process
might
account
observ
alter
intern
andor
tfr
recycl
result
may
use
understand
cme
critic
import
hccl
adipocyt
transdifferenti
clarif
role
play
differenti
express
gene
protein
process
adipogen
transdifferenti
hccl
cultur
provid
basic
foundat
develop
novel
molecul
cancer
therapi
addit
file
support
inform
gene
express
endocyt
pathway
pparg
locu
treatment
albuminassoci
lipid
downregul
upregul
gene
treatment
albuminassoci
lipid
color
blue
red
respect
intens
proport
log
ratio
two
condit
significantli
differenti
express
gene
indic
bold
box
line
addit
file
support
inform
b
gene
express
endocyt
pathway
pparg
locu
treatment
albuminassoci
lipid
b
map
read
gene
express
pparg
locu
shown
pile
map
posit
express
exon
transcript
observ
albumin
incub
